Rochester will be Belgian firm's U.S. headquarters

Posted on January 20th, 2012 by

 Almost $4 million in fresh funding is giving a boost to a Belgium regenerative medicine firm as it gears up its new Rochester office. Cardio3 BioSciences, in which Mayo Clinic owns equity through an intellectual property license, announced Tuesday that it secured almost $4 million, or 3.1 million euros, in its latest round of funding. Additional coverage: Post-Bulletin Blog

Post-Bulletin, by Jeff Kiger, 1/11/2012

Tags: Industry News & Competitive Intelligence

You must be logged-in to the site to post a comment.

Contact Us · Privacy Policy